Vivek Ramaswamy sold $8.5M of Roivant Sciences (ROIV)

Executed Jun 4 2025, disclosed Jun 6 2025, 2 days later.

Value, as filed

$8.5M

748,230 sh across 2 lots

Executed

Jun 4 2025

the trade date, as filed

Disclosed

Jun 6 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Vivek Ramaswamy 10% owner profile →

Vivek Ramaswamy (10% owner) filed 3 Form 4 reports in the trailing twelve months (1 purchase, 2 sales), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $67.9M of ROIV (3,103,745 sh across 3 lots, as filed), executed Dec 11 2025. The median gap between execution and disclosure was 2 days.

The name

ROIV

Roivant Sciences Ltd. ROIV · Healthcare · 75 filings in 24 months ticker →

Healthcare · Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicine…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Vivek Ramaswamy in ROIV

ROIVSALE Roivant Sciences Ltd. $67.9M
3,103,745 sh across 3 lots
Exec Dec 11 2025
Filed Dec 15 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $37.9M
1,854,603 sh across 3 lots
Exec Nov 13 2025
Filed Nov 17 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $22.5M
1,775,749 sh across 3 lots
Exec Sep 3 2025
Filed Sep 5 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $13.1M
1,142,273 sh across 2 lots
Exec Jun 18 2025
Filed Jun 23 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $10.1M
898,959 sh across 2 lots
Exec May 6 2025
Filed May 8 2025 · 5:30 PM ET